|
|
Gene Symbol |
AR |
|
Aliases |
AIS, AR8, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM |
|
Entrez Gene ID |
|
|
Gene Name |
Androgen receptor |
|
Chromosomal Location |
Xq12 |
|
HGNC ID |
|
|
Summary |
The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
SNPs
SNP Id |
Upstream Sequence |
SNP |
Downstream Sequence |
Functional Significance |
References |
rs6152 |
TAGAAGTTCTGATAGCAGAAAAAAGA |
C/T |
GCAGGATTTCCACAGAAGAGAAACT |
Synonymous codon |
20450840 | |
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IMP |
12902338 |
GO:0006351 |
Biological process |
Transcription, DNA-templated |
IDA |
15572661 |
GO:0007165 |
Biological process |
Signal transduction |
TAS |
10835690 |
GO:0007267 |
Biological process |
Cell-cell signaling |
TAS |
10835690 |
GO:0007548 |
Biological process |
Sex differentiation |
NAS |
10075738 |
GO:0008283 |
Biological process |
Cell proliferation |
NAS |
10075738 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IDA |
17277772 |
GO:0008285 |
Biological process |
Negative regulation of cell proliferation |
IMP |
14521927 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IDA |
24681825 |
GO:0010628 |
Biological process |
Positive regulation of gene expression |
IMP |
14521927 |
GO:0030521 |
Biological process |
Androgen receptor signaling pathway |
IDA |
19886863, 20048160 |
GO:0030522 |
Biological process |
Intracellular receptor signaling pathway |
IDA |
17277772 |
GO:0030850 |
Biological process |
Prostate gland development |
NAS |
10075738 |
GO:0042327 |
Biological process |
Positive regulation of phosphorylation |
IMP |
21310825 |
GO:0045597 |
Biological process |
Positive regulation of cell differentiation |
IMP |
14521927 |
GO:0045720 |
Biological process |
Negative regulation of integrin biosynthetic process |
IDA |
21310825 |
GO:0045726 |
Biological process |
Positive regulation of integrin biosynthetic process |
IDA |
21310825 |
GO:0045893 |
Biological process |
Positive regulation of transcription, DNA-templated |
IDA |
11477070, 12799378 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
12799378, 16728402, 17505061, 20048160, 20181722 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IMP |
19345326 |
GO:0045945 |
Biological process |
Positive regulation of transcription by RNA polymerase III |
IDA |
18487222 |
GO:0051092 |
Biological process |
Positive regulation of NF-kappaB transcription factor activity |
IMP |
21310825 |
GO:0051259 |
Biological process |
Protein complex oligomerization |
IDA |
18468998 |
GO:0071383 |
Biological process |
Cellular response to steroid hormone stimulus |
IMP |
12902338 |
GO:1903076 |
Biological process |
Regulation of protein localization to plasma membrane |
IDA |
21310825 |
GO:2001237 |
Biological process |
Negative regulation of extrinsic apoptotic signaling pathway |
IDA |
21310825 |
GO:0000790 |
Cellular component |
Nuclear chromatin |
IDA |
17277772, 17505061 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
15572661, 19345326 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
15572661, 17510388 |
GO:0016607 |
Cellular component |
Nuclear speck |
IDA |
23566155 |
GO:0032991 |
Cellular component |
Protein-containing complex |
IDA |
18468998 |
GO:0000978 |
Molecular function |
RNA polymerase II proximal promoter sequence-specific DNA binding |
IDA |
16728402 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0001085 |
Molecular function |
RNA polymerase II transcription factor binding |
IPI |
16120611 |
GO:0001091 |
Molecular function |
RNA polymerase II basal transcription factor binding |
IPI |
20181722 |
GO:0001228 |
Molecular function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
16728402 |
GO:0003677 |
Molecular function |
DNA binding |
NAS |
10075738 |
GO:0003682 |
Molecular function |
Chromatin binding |
IDA |
21730289 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
11477070, 15572661 |
GO:0003707 |
Molecular function |
Steroid hormone receptor activity |
IDA |
12799378 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
IDA |
12799378, 17277772, 19886863, 20048160, 25091737 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
IMP |
19345326 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
NAS |
10075738 |
GO:0004879 |
Molecular function |
Nuclear receptor activity |
TAS |
15572661 |
GO:0005102 |
Molecular function |
Signaling receptor binding |
IPI |
11875111 |
GO:0005497 |
Molecular function |
Androgen binding |
IDA |
3353726, 25091737 |
GO:0005497 |
Molecular function |
Androgen binding |
NAS |
10075738 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
10075738, 10930412, 10987273, 11477070, 12864730, 14645241, 15563469, 15572661, 16027218, 16051670, 16120611, 16461912, 16494870, 16724108, 16951154, 17108144, 17170703, 17183365, 17202144, 17353003, 17426252, 17510388, 17909037, 18332867, 18451096, 18451177, 18487222, 18640093, 193 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
IDA |
12799378 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
IPI |
12799378 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
TAS |
16344550 |
GO:0008134 |
Molecular function |
Transcription factor binding |
IPI |
12799378 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
17277772, 17587566 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
12799378, 18487222, 19886863 |
GO:0046983 |
Molecular function |
Protein dimerization activity |
NAS |
10075738 |
GO:0051117 |
Molecular function |
ATPase binding |
IDA |
12058073 |
|
Protein Information |
|
Protein Name |
Androgen receptor, dihydrotestosterone receptor, nuclear receptor subfamily 3 group C member 4 |
|
Function |
Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3. .; Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones. |
|
|
|
|
|
UniProt |
|
|
PDB |
1E3G, 1GS4, 1T5Z, 1T63, 1T65, 1XJ7, 1XOW, 1XQ3, 1Z95, 2AM9, 2AMA, 2AMB, 2AO6, 2AX6, 2AX7, 2AX8, 2AX9, 2AXA, 2HVC, 2OZ7, 2PIO, 2PIP, 2PIQ, 2PIR, 2PIT, 2PIU, 2PIV, 2PIW, 2PIX, 2PKL, 2PNU, 2Q7I, 2Q7J, 2Q7K, 2Q7L, 2YHD, 2YLO, 2YLP, 2YLQ, 2Z4J, 3B5R, 3B65, 3B66, 3B67, 3B68, 3BTR, 3L3X, 3L3Z, 3RLJ, 3RLL, 3V49, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000233809 |
|
P18065 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Hypertensive disease |
|
Coronary heart disease |
|
Ear Or Mastoid Diseases |
Meniere Disease |
|
Endocrine System Diseases |
Reifenstein Syndrome |
8325932, 8550758, 9543136, 7910529, 9039340, 10543676, 8097257, 8823308, 10022458, 9329414, 7981687, 7649358, 10221692, 2010552, 1424203, 8824883, 1307250, 14756668, 8809734, 10502786, 9196614, 1430233, 8325950, 10470409, 7671849, 9607727, 8033918, 1303262, 7929841, 8281139, 7970939, 9 |
Male Pseudohermaphroditism |
8205256, 9768671, 1316540, 10502786, 7981687, 7970939, 9607727, 1303262, 9039340, 8097257, 10543676, 9543136, 8823308, 9302173, 8446106, 7671849, 7649358, 7910529, 7909256, 10022458, 8550758, 11587068, 7929841, 8824883, 2010552, 8281139, 8809734, 9329414, 1424203, 1430233, 8325932, 803 |
Androgen-Insensitivity Syndrome |
8809734, 11744994, 9039340, 1775137, 1487249, 7981687, 7581399, 9627582, 16595706, 8830623, 7970939, 7993455, 11587068, 8446106, 8683794, 8647313, 10022458, 7929841, 7641413, 8325950, 9160185, 9856504, 2594783, 9851768, 9698822, 9106550, 9255042, 8413310, 1480178, 7981689, 9302173, 130 |
Androgen Receptor Deficiency |
|
Testicular Feminization |
|
PCOS |
|
Neoplasms |
Prostate cancer |
20729295, 25970160, 23704919, 25908785, 22666205, 16934689, 16998812, 29610475, 25062956, 16877366, 25735316, 12237244, 22610119, 17003774, 16266977, 17141945, 15389811, 19011039, 15790600, 11742035, 18829485, 10363963, 17311914, 7511268, 17591767, 8827083, 19244107, 8274409, 163112, 28757136, 18985049, 24740322 |
Leukemia |
|
Prostatic Intraepithelial Neoplasias |
|
Astrocytoma |
|
Grade I Astrocytoma |
|
Childhood Cerebral Astrocytoma |
|
Breast Cancer,Male |
|
Liver Cancer |
|
Cerebral Astrocytoma |
|
Breast Cancer |
|
Intracranial Astrocytoma |
|
Oligoastrocytoma |
|
Vulvar Cancer |
|
Nervous System Diseases |
Kennedy disease |
10458483, 15925895, 1598912, 28261839, 16083860, 11788673, 26778393, 8040309, 1430233, 8824883, 20011049, 28492532, 12843171, 9768671 |
Psychiatric/Brain disorders |
Mental Depression |
|
Schizophrenia |
|
Mood Disorders |
|
Autistic Disorder |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Hypospadias |
|
Reproductive disorders |
Male infertility |
|
Subfertility, Female |
|
Preeclampsia |
|
Skin and Connective Tissue Diseases |
Alopecia |
|
|
References |
|
|
Xia Yanjie, Che Yena, Zhang Xinlin, Zhang Chengwei, Cao Yunxia, Wang Wenjun, Xu Pei, Wu Xiaoke, Yi Long, Gao Qian, Wang Yong |
Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, PR China. |
Mol Med Rep. 2012 May;5(5):1330-4. doi: 10.3892/mmr.2012.789. Epub 2012 Feb 13. |
Abstract
Human androgen receptor (AR) contains a highly polymorphic polyglutamine tract encoded by CAG repeats [(CAG)n] in exon 1 of the AR gene. The CAG repeats, ranging from 11 to 38, have been reported to be inversely correlated with AR activity. A case-control study involving 261 polycystic ovary syndrome (PCOS) patients and 278 healthy controls was conducted. Fluorescently labeled DNA fragments containing (CAG)n were obtained by PCR and genotyped via capillary electrophoresis. AR (CAG)n ranges were 6, 12-28 in PCOS cases and 9, 10, 12-32 in controls. In the PCOS group, a higher frequency of short (CAG)n alleles was found compared with that of controls (P=0.007). Similarly, CAG biallelic mean distributions also showed statistical difference between the two groups (P=0.025). In conclusion, shorter alleles of the (CAG)n in exon 1 of the AR gene enhanced the susceptibility to PCOS, either by upregulating AR activity or by causing hyperandrogenism. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|